HEADER HYDROLASE(ENDORIBONUCLEASE) 08-AUG-94 1RCL TITLE THE THREE DIMENSIONAL STRUCTURE OF GUANINE-SPECIFIC RIBONUCLEASE F1 IN TITLE 2 SOLUTION DETERMINED BY NMR SPECTROSCOPY AND DISTANCE GEOMETRY COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBONUCLEASE F1; COMPND 3 CHAIN: A; COMPND 4 EC: 3.1.27.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GIBBERELLA FUJIKUROI; SOURCE 3 ORGANISM_TAXID: 5127 KEYWDS HYDROLASE(ENDORIBONUCLEASE) EXPDTA SOLUTION NMR AUTHOR T.NAKAI,W.YOSHIKAWA,H.NAKAMURA,H.YOSHIDA REVDAT 6 06-NOV-24 1RCL 1 REMARK REVDAT 5 25-DEC-19 1RCL 1 SEQADV SEQRES LINK REVDAT 4 29-NOV-17 1RCL 1 REMARK HELIX REVDAT 3 24-FEB-09 1RCL 1 VERSN REVDAT 2 01-APR-03 1RCL 1 JRNL REVDAT 1 30-NOV-94 1RCL 0 JRNL AUTH T.NAKAI,W.YOSHIKAWA,H.NAKAMURA,H.YOSHIDA JRNL TITL THE THREE-DIMENSIONAL STRUCTURE OF GUANINE-SPECIFIC JRNL TITL 2 RIBONUCLEASE F1 IN SOLUTION DETERMINED BY NMR SPECTROSCOPY JRNL TITL 3 AND DISTANCE GEOMETRY. JRNL REF EUR.J.BIOCHEM. V. 208 41 1992 JRNL REFN ISSN 0014-2956 JRNL PMID 1511688 JRNL DOI 10.1111/J.1432-1033.1992.TB17157.X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.NAKAI REMARK 1 TITL ACCURATE DETERMINATION OF PROTEIN CONFORMATIONS BY NUCLEAR REMARK 1 TITL 2 MAGNETIC RESONANCE SPECTROSCOPY AND DISTANCE GEOMETRY AND REMARK 1 TITL 3 ANALYSIS OF THEIR STRUCTURAL FEATURES REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH D.G.VASSYLYEV,K.KATAYANAGI,K.ISHIKAWA,M.TSUJIMOTO-HIRANO, REMARK 1 AUTH 2 M.DANNO,A.PAHLER,O.MATSUMOTO,M.MATSUSHIMA,H.YOSHIDA, REMARK 1 AUTH 3 K.MORIKAWA REMARK 1 TITL CRYSTAL STRUCTURES OF RIBONUCLEASE F1 OF FUSARIUM REMARK 1 TITL 2 MONILIFORME IN ITS FREE FORM AND IN COMPLEX WITH 2'GMP REMARK 1 REF J.MOL.BIOL. V. 230 979 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : EMBOSS, PRESTO REMARK 3 AUTHORS : NAKAI,KIDERA,NAKAMURA (EMBOSS), REMARK 3 MORIKAMI,NAKAI,KIDERA,SAITO,NAKAMURA (PRESTO) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RCL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176019. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 3 84.71 57.66 REMARK 500 ASN A 29 37.80 -176.51 REMARK 500 ASP A 31 157.00 89.63 REMARK 500 ALA A 33 93.84 -61.26 REMARK 500 SER A 35 133.92 71.99 REMARK 500 THR A 37 -32.04 -147.19 REMARK 500 ASN A 44 -156.62 32.72 REMARK 500 TYR A 45 151.35 67.44 REMARK 500 VAL A 52 -114.75 -146.58 REMARK 500 ASP A 53 -56.09 -157.89 REMARK 500 PHE A 59 102.57 -160.21 REMARK 500 TYR A 67 118.24 -3.67 REMARK 500 THR A 68 -51.19 -122.61 REMARK 500 SER A 71 135.34 81.80 REMARK 500 ASN A 82 -86.45 -157.36 REMARK 500 CYS A 83 5.16 -163.22 REMARK 500 ASN A 98 -178.45 -66.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RCK RELATED DB: PDB DBREF 1RCL A 2 106 UNP P10282 RNF1_GIBFU 2 106 SEQADV 1RCL THR A 32 UNP P10282 SER 32 CONFLICT SEQADV 1RCL SER A 36 UNP P10282 THR 36 CONFLICT SEQRES 1 A 106 PCA SER ALA THR THR CYS GLY SER THR ASN TYR SER ALA SEQRES 2 A 106 SER GLN VAL ARG ALA ALA ALA ASN ALA ALA CYS GLN TYR SEQRES 3 A 106 TYR GLN ASN ASP ASP THR ALA GLY SER SER THR TYR PRO SEQRES 4 A 106 HIS THR TYR ASN ASN TYR GLU GLY PHE ASP PHE PRO VAL SEQRES 5 A 106 ASP GLY PRO TYR GLN GLU PHE PRO ILE LYS SER GLY GLY SEQRES 6 A 106 VAL TYR THR GLY GLY SER PRO GLY ALA ASP ARG VAL VAL SEQRES 7 A 106 ILE ASN THR ASN CYS GLU TYR ALA GLY ALA ILE THR HIS SEQRES 8 A 106 THR GLY ALA SER GLY ASN ASN PHE VAL GLY CYS SER GLY SEQRES 9 A 106 THR ASN MODRES 1RCL PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 14 HETNAM PCA PYROGLUTAMIC ACID FORMUL 1 PCA C5 H7 N O3 HELIX 1 H1 ALA A 13 ASN A 29 1 17 SHEET 1 S1 2 THR A 4 CYS A 6 0 SHEET 2 S1 2 THR A 9 TYR A 11 -1 O TYR A 11 N THR A 4 SHEET 1 S2 5 PRO A 39 TYR A 42 0 SHEET 2 S2 5 TYR A 56 ILE A 61 -1 O TYR A 56 N TYR A 42 SHEET 3 S2 5 ASP A 75 ASN A 80 -1 O ILE A 79 N GLN A 57 SHEET 4 S2 5 GLU A 84 HIS A 91 -1 O ILE A 89 N ARG A 76 SHEET 5 S2 5 PHE A 99 CYS A 102 -1 O CYS A 102 N ALA A 88 SSBOND 1 CYS A 6 CYS A 102 1555 1555 2.04 SSBOND 2 CYS A 24 CYS A 83 1555 1555 2.05 LINK C PCA A 1 N SER A 2 1555 1555 1.34 CISPEP 1 TYR A 38 PRO A 39 0 3.04 CISPEP 2 GLY A 54 PRO A 55 0 -1.04 CISPEP 3 SER A 71 PRO A 72 0 -4.00 SITE 1 CAT 4 HIS A 40 GLU A 58 ARG A 76 HIS A 91 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 HETATM 1 N PCA A 1 3.504 11.986 -7.491 1.00 0.00 N HETATM 2 CA PCA A 1 3.582 12.451 -6.101 1.00 0.00 C HETATM 3 CB PCA A 1 2.247 12.044 -5.459 1.00 0.00 C HETATM 4 CG PCA A 1 1.860 10.746 -6.178 1.00 0.00 C HETATM 5 CD PCA A 1 2.482 10.935 -7.560 1.00 0.00 C HETATM 6 OE PCA A 1 2.120 10.332 -8.568 1.00 0.00 O HETATM 7 C PCA A 1 4.792 11.822 -5.409 1.00 0.00 C HETATM 8 O PCA A 1 4.641 10.931 -4.575 1.00 0.00 O HETATM 9 H PCA A 1 4.057 12.347 -8.255 1.00 0.00 H HETATM 10 HA PCA A 1 3.689 13.534 -6.078 1.00 0.00 H HETATM 11 HB2 PCA A 1 2.294 11.932 -4.374 1.00 0.00 H HETATM 12 HB3 PCA A 1 1.497 12.794 -5.710 1.00 0.00 H HETATM 13 HG2 PCA A 1 2.315 9.884 -5.689 1.00 0.00 H HETATM 14 HG3 PCA A 1 0.778 10.628 -6.228 1.00 0.00 H